Abstract: Glucocorticoids help animals respond to stressors but excessive glucocorticoids cause muscle atrophy, while insulin can promote anabolism and growth. In order to compare the glucocorticoids-induced ultrastructural changes between skeletal muscle and cardiac muscle, and investigate the preventive effects of insulin on the changes, eighteen male chicks with similar initial weight were randomly divided into three groups. The two test groups were respectively treated with high-dose dexamethasone alone or together with low-dose insulin by intraperitoneal injection, and the control group was treated with an equal volume of saline solution. The experiment lasted for ten days, and then the body weight, muscle size and ultrastructure in skeletal and cardiac muscles of twelve chicks were qualitatively or quantitatively analyzed. The results showed that high-dose dexamethasone induced obvious skeletal and cardiac muscle atrophy. The differences of ultrastructural changes between skeletal muscle and cardiac muscle (such as for the former or the latter, the intermyofibrillar-and-interfilamentary spaces reducing or enlarging, the mitochondria swelling seriously or enlarging lightly, the myofibril filaments compacting or loosing) suggested that dexamethasone induced skeletal and cardiac muscle atrophy by different mechanisms. Low-dose insulin did not affect the dexamethasone-induced decreases of body weight and skeletal muscle size, but alleviated lightly the dexamethasone-induced ultrastructural changes in skeletal muscle. Different from skeletal muscle, low-dose insulin almost resisted the dexamethasone-induced ultrastructural changes in cardiac muscle.
Introduction
Glucocorticoids are indispensable for regulating normal physiological activity and helping animals respond to stressors such as starvation, cold or heat and panic. However, excessive glucocorticoids secretion caused by various stress situations promotes muscular atrophy and inhibits growth and development in animals. The high-dose glucocorticoids treatment decreased the bodyweight and muscle mass in young quail (Hull et al. 2007 ) and chickens (Lin et al. 2006) . Glucocorticoids induced muscle atrophy by promoting the catabolism and inhibiting anabolism. The involved part molecular and cellular mechanisms have been investigated in succession in mammals (Auclair et al. 1997; Hasselgren 1999; Shah et al. 2000a, b; Penner et al. 2002; Komamura et al. 2003; Ma et al. 2003; Liu et al. 2004; Gilson et al. 2007; Schakman et al. 2008a ). Compared to mammals, the researches for the functional mechanisms of glucocorticoids in avians are fewer. The corticosterone treatment retarded the growth of skeletal muscle in broiler chickens by suppressed protein synthesis and augmented protein catabolism (Dong et al. 2007 ). Contrary to glucocorticoids, insulin is a hormone which promotes anabolism and inhibits catabolism. Insulin deficiency led to the loss of muscle mass by increasing protein catabolism. A stimulatory effect of insulin on protein synthesis was demonstrated in various tissues, including skeletal muscle (O'Connor et al. 2003) . Apparently, insulin may resist some side-effects of glucocorticoids and appropriate dose of insulin may improve the growth and development of animals. However, excessive insulin is hazardous to health by causing hypoglycemia. Moreover, in some cases, glucocorticoids produced whole body insulin resistance in mammal and avian (Qi & Rodrigues 2007; Yuan et al. 2008 ). The functional complexity of glucocorticoids and insulin means the diversity of their interaction. The interactions of lowdose insulin and high-dose dexamethasone on the ultrastructure of skeletal muscle and cardiac muscle remain unclear. In this study, we aimed at mimicking stress by exposing chicks to dexamethasone, and comparing the dexamethasone-induced skeletal and cardiac muscle atrophy and investigating the preventive effects of low-dose insulin on the pathological role of high-dose dexamethasone at the integrative and ultrastructural level.
Material and methods
Animal care and experimental treatment All animals were maintained under the guidelines for the care and use of laboratory animals at Shanxi Agricultural University. Eighteen male chicks with similar initial weight (about 230 g) were selected from some chicks raised in laboratory, routinely fed and randomly divided into three groups (control group, dexamethasone alone group, and dexamethasone together with insulin group). The two test groups were respectively treated with 1ml dexamethasone sodium phosphate injection (synthetic glucocorticoid, 20 mg/kg/day) alone or together with insulin injection (porcine insulin, 1.5 U/kg/day) by intraperitoneal injection, and the control group was treated with an equal volume of saline solution (0.9% NaCl). The experimental treatment lasted for ten days.
Measure of body weight and muscle size, and muscle collection After the experimental treatment, twelve chicks (four of each group) were randomly selected and weighed and humanely killed. The ipsilateral thigh muscle or cardiac muscle (1 mm 2 × 2 mm) at the same position were removed promptly and fixed in 2.5% glutaraldehyde in 0.2 M phosphate buffered saline (pH 7.2) at 4
• C for subsequent ultrastructure analyses. The length and maximum diameter of the ipsilateral tibialis anterior muscle were measured by vernier caliper.
Transmission electron microscopy (TEM) analysis of muscle After initially fixed in 2.5% glutaraldehyde for 2 h, the samples were washed in buffer for three times (15 min every time) and fixed in 1% osmium tetroxide in 0.1 M phosphate buffered saline for 1 h. Samples were then dehydrated and infiltrated with propylene oxide followed by embedding directionally in araldite (1 mm 3 ). Ultrathin (50-70 nm) longitudinal sections of muscles were cut using a Leica EM UC6 (Leica, Austria). Sections were stained with uranyl acetate and lead citrate according to standard protocols and viewed on JEOL-1400 TEM (Transmission Electron Microscope) (JEOL, Japan).
A total of three muscle fibres were photographed from each muscle sample by Gatan Orius CCD camera (Gatan Inc. USA). For each of the fibres per muscle sample, a total of 10 images (25,000× or 20,000× magnification for skeletal or cardiac muscle) were digitized and analyzed by Gantan DigitalMicrograph Software (Gatan Inc. USA). In brief, the Z line length and the sarcomere length were directly measured as actual length. The mitochondria, myofibril and intermyofibrillar-and-interfilamentary spaces were respectively circled, converted to particle area, and then converted to actual area. Thus, four values, including the mean Z line length, the mean sarcomere length, the mean individual mitochondria area and the area ratio of X to Y for every sample, were obtained and used for further statistical analysis. X represented the intermyofibrillar-and-interfilamentary total space (except for mitochondria), and Y represented the total space of myofibril and mitochondria.
Statistical analysis
All data were analyzed by the paired-samples t-test procedure of SPSS 12.0 statistical software. P < 0.01 or P < 0.05 denote statistical significance. The figures were made using Microsoft Excel 2010.
Results

Effects of dexamethasone alone or with insulin on chick growth and development
Although the chicks treated with high-dose dexamethasone alone remained growing (body weights increased by 60 g), their body weight and skeletal muscle size decreased obviously compared with the control group (P < 0.01) (Table 1, Fig.1 ). The body weight, the length and maximum diameter of tibialis anterior declined by 28. 40%, 14.19% and 16.19%, respectively . However, the heart weight was not obviously affected by highdose dexamethasone alone although the ratio of heart weight to body weight increased significantly by 29.00% (Table 1) . For all the indexes in Table 1 , there were Explanations: Values are expressed as means ± SEM. Values with different superscript upper case letters within the same column differ significantly (P < 0.01). Because the majority of Z lines in cardiac muscle were eroded away after the dexamethasone (Dex) treatment, the mean Z line length were not determined and showed "/". not obvious differences between the dexamethasonewith-insulin group and the dexamethasone-alone group, which showed that low-dose insulin did not affect the dexamethasone-induced decreases of body weight and muscle size.
Effects of dexamethasone alone or with insulin on chick skeletal muscle ultrastructure In accordance with the changes of body weight and skeletal muscle size, the skeletal muscle ultrastructure in chick was obviously affected by high-dose dexam- ethasone alone. The intermyofibrillar spaces (containing abundant mitochondria, glycogen granules, lipids and so on in the control group) were almost lost, the myofibrils lost normal form and became dwindled and overcrowded, and the characteristic areas of A and I bands along the myofibrils became faint (Figs 2A, B) . It was noticeable that mitochondria became swollen and their cristae were disorganized (Fig. 2B1) . In some regions, several myofibrils and their characteristic areas of A, I and Z bands were eroded away and totally disoriented (Data were not shown), and some mitochondria were vacuolar (Fig. 2B2) . Further quantitative analysis results showed that high-dose dexamethasone decreased significantly the mean Z line length by 29.33%, decreased significantly the area ratio of intermyofibrillarand-interfilamentary spaces (except for mitochondria)
to myofibrillar-and-mitochondrial spaces by 77.27%, and increased significantly the mean individual mitochondrial area by 136.73% in skeletal muscle (P < 0.01), but did not affect the mean sarcomere length of skeletal muscle (Table 2 , Fig. 4) . Different from the effects of insulin on the dexamethasone-induced decreases of body weight and skeletal muscle size, low-dose insulin seemed to alleviate the dexamethasone-induced skeletal muscle atrophy at the ultrastructural level (Figs 2A-C) . Most of myofibrils and intermyofibrillar mitochondria, glycogen granules and lipids tended to recover (Fig. 2C) . Further quantitative analysis results showed that insulin alleviated significantly the dexamethasone-induced decrease of the area ratio of intermyofibrillar-and-interfilamentary spaces (except for mitochondria) to myofibrillar-and- mitochondrial spaces by 35.29% and the dexamethasone-induced increase of the mean individual mitochondrial area by 76.12% (Fig. 4) . Insulin tended to alleviate the dexamethasone-induced decrease of the mean Z line length but no significant difference ( Table 2) .
Effects of dexamethasone alone or with insulin on chick cardiac muscle ultrastructure Compared to the normal skeletal myofiber, there were more abundant mitochondria in the normal cardiac myofiber (Figs 2A, 3A) . Different from the unchanged heart weight, the ultrastructure of chick cardiac muscle was obviously affected by high-dose dexamethasone alone (Figs 3A, B) . The intermyofibrillar-andinterfilamentary spaces (except for mitochondria) were apparently enlarged. The myofibrils lost normal form and became dwindled and loose, and the characteristic areas of A, I and Z bands along the myofibrils became disorganized and were eroded away. Further quantitative analysis results showed that high-dose dexamethasone increased significantly the area ratio of intermyofibrillar-and-interfilamentary spaces (except for mitochondria) to myofibrillar-and-mitochondrial spaces by 141.67%, and the mean individual mitochondrial area by 13.33% (P < 0.01), but did not obviously affect the mean sarcomere length in cardiac muscle (Fig. 4, Table 2 ). The majority of Z lines in cardiac muscle were eroded away after the dexamethasone treatment so that the mean Z line length could not be measured ( Table 2) .
The observation results showed that low-dose insulin almost resisted the dexamethasone-induced cardiac muscle atrophy at the ultrastructural level ( Figs 3A-C) . The myofibrils and the intermyofibrillarand-interfilamentary spaces in the dexamethasonewith-insulin group were similar to those in the control group although some slight differences existed. Further quantitative analysis results showed that lowdose insulin alleviated significantly the dexamethasoneinduced increase of the area ratio of intermyofibrillarand-interfilamentary spaces (except for mitochondria) to myofibrillar-and-mitochondrial spaces by 88.24%, and resisted entirely the dexamethasone-induced increase of the mean individual mitochondrial area and erosion of Z lines (Table 2, Fig. 4 ).
Discussion
Different effects of high-dose dexamethasone on skeletal and cardiac muscle The hypogenesis of whole body and the slow increase of body weight in the dexamethasone-treated chicks showed the systemic effects of dexamethasone on the growth and development. The measure of muscle size and the observation of muscle ultrastructure showed that high-dose dexamethasone induced serious skeletal muscle atrophy. The mechanisms by which glucocorticoids induce skeletal muscle atrophy should be very complex since many proteins were involved in the course. According to some researches for mammals, excessive glucocorticoids causing skeletal muscle atrophy in avian might be due to: (1) promoting proteolysis in muscle by stimulating the expression of proteins such as E3-ligases, atrogin-1, MuRF-1 (muscle ring finger 1), and the lysosomal enzyme cathepsin L in the ubiquitinproteolytic pathways (Auclair et al. 1997; Hasselgren 1999; Marinovic et al. 2002; Combaret et al. 2005; Baehr et al. 2010) ; (2) limiting the protein synthesis by inhibiting the transport of amino acids into the muscle and inhibiting the stimulatory action of insulin, IGF-I (insulin-like growth factor-I), and amino acids on the phosphorylation of eIF4E-binding protein 1 (4E-BP1) and the ribosomal protein S6 kinase 1 (S6K1) (Shah et al. 2000a, b; Liu et al. 2004; Schakman et al. 2008b ). In addition, the upregulation of myostatin and FOXO and the downregulation of IGF-I and myogenin might take part responsibility for the dexamethasone-induced skeletal muscle atrophy in chick according to some researches for mammals in vitro as well in vivo (Lang et al. 2001; Ma et al. 2001 Ma et al. , 2003 Sandri et al. 2004; Gilson et al. 2007; Du et al. 2007; Schakman et al. 2008b; Zheng et al. 2010) . However, the ultrastructural results in our study showed that the diminishment in skeletal muscle size was not only attributed to the dwindlement of myofibrils but to the decreases of glycogen granules, lipids and other components in in-termyofibrillar and interfilamentary spaces. It was noticeable that the dexamethasone-induced skeletal muscle atrophy was companied with the mitochondria swell in chicks. Mitochondria are the powerhouse of the cell and play a vital role in the energy metabolism and apoptosis (Paul & Mukhopadhyay 2007) . Azad et al. (2010) showed that chronic heat stress increased oxygen consumption rate and ROS (reactive oxygen species) production in skeletal muscle mitochondria of broiler chicken. Amthor et al. (2007) showed that the ratio of mitochondrial DNA to nuclear DNA and the mitochondria number were decreased in myostatin-deficient mice muscle. Thus, the mitochondria swell of chicks exposed to dexamethasone might be due to the adaptability to the increasing catabolism or might be associated with the dexamethasone-induced upregulation of myostatin expression.
Different from the change of body weight, highdose dexamethasone did not affect the heart weight of chicks, so the dexamethasone-induced increase in the ratio of heart weight to body weight was entirely attributed to the decrease of body weight. It suggested glucocorticoids' pivotal role in the pathogenesis of central obesity in avian. In brief, high-dose dexamethasone promoted the secretion of endogenous insulin by regulating glucose metabolism, and different from limbs of body, the central position of body was more sensitive to insulin than to dexamethasone. Thus, the increasing endogenous insulin promoted the anabolism of the central position of body such as heart. Apparently, the increase of intermyofibrillar and interfilamentary spaces (except for mitochondria), where contain abundant glycogen granules, lipids and other components, was a direct evidence. However, to our surprise, the serious dwindlement and erosion of cardiac myofibrils in the dexamethasone-alone group seemed to disobey to the above central obesity view. It suggested that dexamethasone induced the cardiac myofibrils degradation by other more complex mechanisms. Unlike in the skeletal muscle, the size of mitochondria in cardiac muscle was changed lightly by dexamethasone, which might be due to enough abundant mitochondria in normal cardiac muscle itself. Compared to the skeletal muscle, fewer myostatin proteins were expressed in the cardiac muscle. As for the effect of myostatin on cardiac muscle, there remain debates (Morissette et al. 2006; Cohn et al. 2007 ). However, it could not be excluded that dexamethasone induced cardiac myofibrils degradation might be associated with the upregulation of myostatin expression.
Insulin alleviated to different degree the pathological role of dexamethasone on skeletal and cardiac muscle In this study, insulin alleviated, although to a small degree, the dexamethasone-induced myofibrils dwindlement and intermyofibrillar-and-interfilamentary spaces (except for mitochondria) decreases of skeletal muscle. It looked reasonable to explain the reason why insulin alleviated dexamethasone-induced skeletal muscle atrophy by our previous knowledge: dexamethasone promotes the catabolism and inhibits anabolism while insulin promotes anabolism and inhibits catabolism. Many experiments have shown that insulin can acutely stimulate muscle protein synthesis by increasing the initiation of mRNA translation, muscle blood flow, amino acid delivery and availability (Kimball et al. 1997 (Kimball et al. , 1998 Fujita et al. 2006) . Although insulin alleviated the dexamethasone-induced microstructural changes of skeletal muscle fibers, it was not enough to affect the dexamethasone-induced macrostructural changes (such as weight decrease and muscle dwindlement). It was noteworthy that low-dose insulin inhibited strongly the dexamethasone-induced mitochondria swell of skeletal muscle. Apparently, low-dose insulin ameliorated acutely the mitochondrial function in chicks, which might be related to the acceleration of mitochondrial protein synthesis rates and mitochondrial oxidative phosphorylation (Stump et al. 2003; Orellana et al. 2009 ). Chen et al. (2009) showed that insulin attenuated the upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice. However, Barazzoni et al. (2004) showed that myostatin expression was not increased under catabolic conditions in insulin-deprived diabetes and insulin treatment also did not change myostatin transcript levels. These research results urged us to think whether myostatin was associated with insulin's prevention to the dexamethasoneinduced skeletal muscle atrophy.
Similar to the skeletal muscle, low-dose insulin protected to a large degree the mitochondria function of cardiac muscle in chicks. Different from the skeletal muscle, the preventive role of insulin in the dexamethasone-induced cardiac muscle atrophy was more obvious. Both the observation results and the quantitative analysis results showed that low-dose insulin almost resisted the dexamethasone-induced cardiac myofibrils degradation. It might be related to the different sensitivity of two kinds of muscle to insulin. However, low-dose insulin decreased significantly the dexamethasone-induced increase of intermyofibrillar and interfilamentary spaces (except for mitochondria) where contained abundant glycogen granules, lipids and other components. It was not accordant with the promoting-anabolism function of insulin. The complex dose-response relationship, feedback mechanism of endogenous and exogenous insulin, interaction of many related molecules and other mechanisms might be involved.
All in all, our results showed that high-dose dexamethasone induced different ultrastructural changes of skeletal and cardiac muscle in chicks, and low-dose insulin alleviated the changes to different degree. Although glucocorticoids could produce insulin resistance in mammal and avian (Qi & Rodrigues 2007; Yuan et al. 2008 ) and the dexamethasone-induced muscle size decreases were not affected by insulin in this study, the appropriate exogenous insulin could partly reverse the dexamethasone-induced ultrastructural muscle damage. The discriminatory effects of dexamethasone and the discriminatory interactions of insulin-dexamethasone on the ultrastructure of skeletal muscle and cardiac muscle in chicks suggested that the interactive complexity of endogenous or exogenous glucocorticoids and insulin. It is imperative for us to further research the relevant problems or hypotheses mentioned above before long.
